Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2, Kidney Disease, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Not applicableActive Not RecruitingNCT07541729
What this trial is testing

Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Oxidative StressInflammation Chronic
Universidad Autonoma de Zacatecas 40
Large-scale testing (Phase 3)Study completedNCT01986855
What this trial is testing

The Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 468
Not applicableStudy completedNCT05465317
What this trial is testing

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 62,197
Not applicableStudy completedNCT03157960
What this trial is testing

Effect of Acute Fructose Load in Human

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2
Karolinska University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02358096
What this trial is testing

Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Astellas Pharma Europe B.V. 125
Not applicableStudy completedNCT03921242
What this trial is testing

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Weill Medical College of Cornell University 4,888
Not applicableStudy completedNCT04190251
What this trial is testing

PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 73
Testing effectiveness (Phase 2)Study completedNCT05254002
What this trial is testing

Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 1,664
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Not applicableStudy completedNCT04006028
What this trial is testing

Kidney Biopsy Indications in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes, Chronic Kidney Disease
Rennes University Hospital 500
Not applicableStudy completedNCT07672639
What this trial is testing

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Beijing Tongren Hospital 2,201
Large-scale testing (Phase 3)Study completedNCT05998837
What this trial is testing

GLUcose Transport and REnalPROtection in Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseDiabetes Mellitus, Type 2Hypertension
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 34
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT06820567
What this trial is testing

Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD

Who this might be right for
Chronic Kidney DiseasesDiabetes Type 2
Assiut University 210
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Post-approval studies (Phase 4)Study completedNCT01448174
What this trial is testing

Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients

Who this might be right for
Renal Failure Chronic Requiring HemodialysisMetabolic SyndromeDiabetes Mellitus Type 2+1 more
Poznan University of Medical Sciences 310
Testing effectiveness (Phase 2)Study completedNCT01955694
What this trial is testing

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone

Who this might be right for
Heart Failure
Bayer 72
Not applicableStudy completedNCT05703880
What this trial is testing

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 15,948
Not applicableStudy completedNCT06659718
What this trial is testing

Emulation of the SOUL Diabetes Trial in Healthcare Claims

Who this might be right for
Diabetes Mellitus, Type 2
Brigham and Women's Hospital 43,650
Next Page